WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H341436
CAS#: 19179-78-3
Description: Xipranolol is a biochemical.
Hodoodo Cat#: H341436
Name: Xipranolol
CAS#: 19179-78-3
Chemical Formula: C23H33NO2
Exact Mass: 355.25
Molecular Weight: 355.522
Elemental Analysis: C, 77.70; H, 9.36; N, 3.94; O, 9.00
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Xipranolol;
IUPAC/Chemical Name: 1-(Di-2,6-xylylmethoxy)-3-(isopropylamino)-2-propanol
InChi Key: NCDUZGLNHCZFNZ-UHFFFAOYSA-N
InChi Code: InChI=1S/C23H33NO2/c1-15(2)24-13-20(25)14-26-23(21-16(3)9-7-10-17(21)4)22-18(5)11-8-12-19(22)6/h7-12,15,20,23-25H,13-14H2,1-6H3
SMILES Code: OC(CNC(C)C)COC(C1=C(C)C=CC=C1C)C2=C(C)C=CC=C2C
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 355.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Chino D, Sone T, Yamazaki K, Tsuruoka Y, Yamagishi R, Shiina S, Obara K, Yamaki F, Higai K, Tanaka Y. Pharmacological identification of β-adrenoceptor subtypes mediating isoprenaline-induced relaxation of guinea pig colonic longitudinal smooth muscle. J Smooth Muscle Res. 2018;54(0):13-27. doi: 10.1540/jsmr.54.13. PubMed PMID: 29540623; PubMed Central PMCID: PMC5863046.
2: Markiewicz W, Jaroszewski JJ. Influence of β2- and β3-adrenoceptor agonists on contractile activity of the porcine myometrium in the luteal phase and the first days of pregnancy. Pol J Vet Sci. 2017 Mar 28;20(1):111-121. doi: 10.1515/pjvs-2017-0015. PubMed PMID: 28525334.
3: Markiewicz W, Jaroszewski JJ. β- and β-adrenergic receptors stimulation relaxes porcine myometrium in the peri-implantation period. J Anim Sci. 2016 Nov;94(11):4611-4618. doi: 10.2527/jas.2016-0577. PubMed PMID: 27898948.
4: Martin LJ, Piltonen MH, Gauthier J, Convertino M, Acland EL, Dokholyan NV, Mogil JS, Diatchenko L, Maixner W. Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers. J Pain. 2015 Dec;16(12):1321-1333. doi: 10.1016/j.jpain.2015.09.004. Epub 2015 Oct 9. PubMed PMID: 26456674.
5: Liu P, Li S, Jin Y, Qian L, Gao N, Yao SQ, Huang F, Xu QH, Cao Y. Red-emitting DPSB-based conjugated polymer nanoparticles with high two-photon brightness for cell membrane imaging. ACS Appl Mater Interfaces. 2015 Apr 1;7(12):6754-63. doi: 10.1021/acsami.5b00223. Epub 2015 Mar 23. PubMed PMID: 25764496.
6: Ma Y, Zhang H, Rahman ZU, Wang W, Li X, Chen H, Chen X. Sensitive enantioanalysis of β-blockers via field-amplified sample injection combined with water removal in microemulsion electrokinetic chromatography. Electrophoresis. 2014 Oct;35(19):2772-7. doi: 10.1002/elps.201400008. Epub 2014 Jun 20. PubMed PMID: 24798241.
7: Schlicker E, Pędzińska-Betiuk A, Kozłowska H, Szkaradek N, Żelaszczyk D, Baranowska-Kuczko M, Kieć-Kononowicz K, Marona H, Malinowska B. MH-3: evidence for non-competitive antagonism towards the low-affinity site of β1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 2014 Aug;387(8):743-52. doi: 10.1007/s00210-014-0983-3. Epub 2014 May 3. PubMed PMID: 24788554.
8: Servais AC, Fillet M. Enantioseparations in nonaqueous capillary electrophoresis using charged cyclodextrins. Methods Mol Biol. 2013;970:297-305. doi: 10.1007/978-1-62703-263-6_19. PubMed PMID: 23283786.
9: Pedzińska-Betiuk A, Modzelewska B, Jóźwik M, Jóźwik M, Kostrzewska A. Differences in the effects of beta2- and beta3-adrenoceptor agonists on spontaneous contractions of human nonpregnant myometrium. Ginekol Pol. 2011 Dec;82(12):918-24. PubMed PMID: 22384628.
10: Christ T, Molenaar P, Klenowski PM, Ravens U, Kaumann AJ. Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature. Br J Pharmacol. 2011 Feb;162(4):823-39. doi: 10.1111/j.1476-5381.2010.00996.x. PubMed PMID: 20726983; PubMed Central PMCID: PMC3042194.
11: Mishra B, Sankar C, Mishra M. Polymer based solutions of bupranolol hydrochloride for intranasal systemic delivery. J Drug Target. 2011 Apr;19(3):204-11. doi: 10.3109/1061186X.2010.492520. Epub 2010 Jun 15. PubMed PMID: 20550434.
12: Hsu IR, Zuniga E, Bergman RN. Pulsatile changes in free fatty acids augment hepatic glucose production and preserves peripheral glucose homeostasis. Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E131-6. doi: 10.1152/ajpendo.00427.2009. Epub 2010 Apr 27. PubMed PMID: 20424137; PubMed Central PMCID: PMC2904046.
13: Pujos E, Cren-Olivé C, Paisse O, Flament-Waton MM, Grenier-Loustalot MF. Comparison of the analysis of beta-blockers by different techniques. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):4007-14. doi: 10.1016/j.jchromb.2009.10.014. Epub 2009 Oct 17. PubMed PMID: 19879818.
14: Zelaszczyk D, Kozlowska H, Baranowska U, Baranowska M, Reutelsterz A, Kiec-Kononowicz K, Malinowska B, Schlicker E. Four close bupranolol analogues are antagonists at the low-affinity state of beta1-adrenoceptors. J Physiol Pharmacol. 2009 Mar;60(1):51-60. PubMed PMID: 19439807.
15: Pedzinska-Betiuk A, Modzelewska B, Kostrzewska A, Jozwik M. Influence of potent and selective beta-adrenoceptor agonist, CL 316243, on the contractile response of non-pregnant human myometrium. J Physiol Pharmacol. 2008 Dec;59 Suppl 9:43-54. PubMed PMID: 19261970.
16: Skeberdis VA, Gendviliene V, Zablockaite D, Treinys R, Macianskiene R, Bogdelis A, Jurevicius J, Fischmeister R. beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current. J Clin Invest. 2008 Sep;118(9):3219-27. doi: 10.1172/JCI32519. PubMed PMID: 18704193; PubMed Central PMCID: PMC2515379.
17: Holopherne D, Mallem MY, Le Strat E, Belin de Chantemèle EJ, Gogny M, Henrion D, Noireaud J, Desfontis JC. CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats. Eur J Pharmacol. 2008 Sep 4;591(1-3):196-202. doi: 10.1016/j.ejphar.2008.06.060. Epub 2008 Jun 19. PubMed PMID: 18601917.
18: Babu RJ, Dhanasekaran M, Vaithiyalingam SR, Singh PN, Pandit JK. Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers. Life Sci. 2008 Jan 30;82(5-6):273-8. Epub 2007 Nov 23. PubMed PMID: 18096189.
19: Gagyi L, Gyéresi A, Kilár F. Role of chemical structure in stereoselective recognition of beta-blockers by cyclodextrins in capillary zone electrophoresis. J Biochem Biophys Methods. 2008 Apr 24;70(6):1268-75. Epub 2007 Oct 13. PubMed PMID: 18022245.
20: Clouse AK, Riedel E, Hieble JP, Westfall TD. The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder. Eur J Pharmacol. 2007 Nov 14;573(1-3):184-9. Epub 2007 Jun 27. PubMed PMID: 17632099.
